Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harte Hanks (HHS) Share-based Compensation (2016 - 2025)

Harte Hanks (HHS) has disclosed Share-based Compensation for 16 consecutive years, with $150000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Share-based Compensation fell 59.24% to $150000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $598000.0, a 68.0% decrease, with the full-year FY2024 number at $1.9 million, up 36.18% from a year prior.
  • Share-based Compensation was $150000.0 for Q3 2025 at Harte Hanks, down from $220000.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $900000.0 in Q3 2022 to a low of -$49000.0 in Q1 2025.
  • A 5-year average of $392894.7 and a median of $368000.0 in 2024 define the central range for Share-based Compensation.
  • Peak YoY movement for Share-based Compensation: surged 1376.0% in 2021, then crashed 108.88% in 2025.
  • Harte Hanks' Share-based Compensation stood at $369000.0 in 2021, then soared by 56.91% to $579000.0 in 2022, then plummeted by 62.87% to $215000.0 in 2023, then increased by 28.84% to $277000.0 in 2024, then plummeted by 45.85% to $150000.0 in 2025.
  • Per Business Quant, the three most recent readings for HHS's Share-based Compensation are $150000.0 (Q3 2025), $220000.0 (Q2 2025), and -$49000.0 (Q1 2025).